Literature DB >> 20473152

Genetics of type 2 diabetes.

Galina Smushkin1, Adrian Vella.   

Abstract

PURPOSE OF REVIEW: To provide an overview of the genetics of type 2 diabetes in the context of recent progress in the understanding of the genetic architecture of the disease and its applicability to the pathogenesis of the disease as well as efforts to individualize therapy in type 2 diabetes. Efforts are underway to understand how these loci alter measurable physiologic processes in nondiabetic humans. However, it is important to understand the potential pitfalls in such studies and the limitations underlying measurement of insulin secretion and action using qualitative methodologies. RECENT
FINDINGS: The availability of large population-based cohorts and the ease with which large numbers of common genetic variants can be genotyped has enabled the discovery of multiple loci and pathways associated with type 2 diabetes. Recent efforts examining quantitative traits such as fasting glucose concentrations have led to the discovery of other genes likely to be important in the development of diabetes.
SUMMARY: The past 4 years have witnessed a significant increase in our understanding of genetic predisposition to type 2 diabetes. Hopefully more progress will be made in applying this knowledge to the pathophysiology of type 2 diabetes in the coming years.

Entities:  

Mesh:

Year:  2010        PMID: 20473152      PMCID: PMC2953639          DOI: 10.1097/MCO.0b013e32833a558d

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  49 in total

1.  Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity.

Authors:  E Breda; M K Cavaghan; G Toffolo; K S Polonsky; C Cobelli
Journal:  Diabetes       Date:  2001-01       Impact factor: 9.461

2.  TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta.

Authors:  Fenghua Yi; Patricia L Brubaker; Tianru Jin
Journal:  J Biol Chem       Date:  2004-11-02       Impact factor: 5.157

Review 3.  Genome-wide association studies: theoretical and practical concerns.

Authors:  William Y S Wang; Bryan J Barratt; David G Clayton; John A Todd
Journal:  Nat Rev Genet       Date:  2005-02       Impact factor: 53.242

4.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.

Authors:  Struan F A Grant; Gudmar Thorleifsson; Inga Reynisdottir; Rafn Benediktsson; Andrei Manolescu; Jesus Sainz; Agnar Helgason; Hreinn Stefansson; Valur Emilsson; Anna Helgadottir; Unnur Styrkarsdottir; Kristinn P Magnusson; G Bragi Walters; Ebba Palsdottir; Thorbjorg Jonsdottir; Thorunn Gudmundsdottir; Arnaldur Gylfason; Jona Saemundsdottir; Robert L Wilensky; Muredach P Reilly; Daniel J Rader; Yu Bagger; Claus Christiansen; Vilmundur Gudnason; Gunnar Sigurdsson; Unnur Thorsteinsdottir; Jeffrey R Gulcher; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2006-01-15       Impact factor: 38.330

5.  Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.

Authors:  David M Kendall; Matthew C Riddle; Julio Rosenstock; Dongliang Zhuang; Dennis D Kim; Mark S Fineman; Alain D Baron
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

Review 6.  Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects.

Authors:  E Ferrannini
Journal:  Endocr Rev       Date:  1998-08       Impact factor: 19.871

7.  Effects of changing diagnostic criteria on the risk of developing diabetes.

Authors:  S F Dinneen; D Maldonado; C L Leibson; G G Klee; H Li; L J Melton; R A Rizza
Journal:  Diabetes Care       Date:  1998-09       Impact factor: 19.112

Review 8.  Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes.

Authors:  Andrew T Hattersley; Ewan R Pearson
Journal:  Endocrinology       Date:  2006-03-23       Impact factor: 4.736

9.  A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk.

Authors:  Nabila Bouatia-Naji; Amélie Bonnefond; Christine Cavalcanti-Proença; Thomas Sparsø; Johan Holmkvist; Marion Marchand; Jérôme Delplanque; Stéphane Lobbens; Ghislain Rocheleau; Emmanuelle Durand; Franck De Graeve; Jean-Claude Chèvre; Knut Borch-Johnsen; Anna-Liisa Hartikainen; Aimo Ruokonen; Jean Tichet; Michel Marre; Jacques Weill; Barbara Heude; Maithé Tauber; Katleen Lemaire; Frans Schuit; Paul Elliott; Torben Jørgensen; Guillaume Charpentier; Samy Hadjadj; Stéphane Cauchi; Martine Vaxillaire; Robert Sladek; Sophie Visvikis-Siest; Beverley Balkau; Claire Lévy-Marchal; François Pattou; David Meyre; Alexandra I F Blakemore; Marjo-Riita Jarvelin; Andrew J Walley; Torben Hansen; Christian Dina; Oluf Pedersen; Philippe Froguel
Journal:  Nat Genet       Date:  2008-12-07       Impact factor: 38.330

10.  Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms.

Authors:  Adrian Vella; Jason D Cooper; Christopher E Lowe; Neil Walker; Sarah Nutland; Barry Widmer; Richard Jones; Susan M Ring; Wendy McArdle; Marcus E Pembrey; David P Strachan; David B Dunger; Rebecca C J Twells; David G Clayton; John A Todd
Journal:  Am J Hum Genet       Date:  2005-03-17       Impact factor: 11.025

View more
  14 in total

1.  Charting a course for genomic medicine from base pairs to bedside.

Authors:  Eric D Green; Mark S Guyer
Journal:  Nature       Date:  2011-02-10       Impact factor: 49.962

2.  Circadian variation of the pancreatic islet transcriptome.

Authors:  Kuntol Rakshit; Jingyi Qian; Jason Ernst; Aleksey V Matveyenko
Journal:  Physiol Genomics       Date:  2016-08-05       Impact factor: 3.107

3.  A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations.

Authors:  Airani Sathananthan; Chiara Dalla Man; Alan R Zinsmeister; Michael Camilleri; Richard J Rodeheffer; Gianna Toffolo; Claudio Cobelli; Robert A Rizza; Adrian Vella
Journal:  Clin Endocrinol (Oxf)       Date:  2012-02       Impact factor: 3.478

4.  Development of diabetes does not alter behavioral and molecular circadian rhythms in a transgenic rat model of type 2 diabetes mellitus.

Authors:  Jingyi Qian; Anthony P Thomas; Analyne M Schroeder; Kuntol Rakshit; Christopher S Colwell; Aleksey V Matveyenko
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-05-02       Impact factor: 4.310

5.  What is type 2 diabetes?

Authors:  Galina Smushkin; Adrian Vella
Journal:  Medicine (Abingdon)       Date:  2010-11-01

Review 6.  Resistance to type 2 diabetes mellitus: a matter of hormesis?

Authors:  Hubert Kolb; Décio L Eizirik
Journal:  Nat Rev Endocrinol       Date:  2011-10-25       Impact factor: 43.330

Review 7.  The islet circadian clock: entrainment mechanisms, function and role in glucose homeostasis.

Authors:  K Rakshit; J Qian; C S Colwell; A V Matveyenko
Journal:  Diabetes Obes Metab       Date:  2015-09       Impact factor: 6.577

Review 8.  Effect of maternal PCOS and PCOS-like phenotype on the offspring's health.

Authors:  Muraly Puttabyatappa; Rodolfo C Cardoso; Vasantha Padmanabhan
Journal:  Mol Cell Endocrinol       Date:  2015-11-27       Impact factor: 4.102

Review 9.  Circadian Etiology of Type 2 Diabetes Mellitus.

Authors:  Naureen Javeed; Aleksey V Matveyenko
Journal:  Physiology (Bethesda)       Date:  2018-03-01

10.  Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1.

Authors:  Galina Smushkin; Matheni Sathananthan; Airani Sathananthan; Chiara Dalla Man; Francesco Micheletto; Alan R Zinsmeister; Claudio Cobelli; Adrian Vella
Journal:  Diabetes       Date:  2012-03-28       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.